Senior officials within the Food and Drug Administration's (FDA) tobacco center were reportedly blindsided by a sudden policy shift that opens the U.S. market to unauthorized electronic cigarettes and nicotine pouches. The controversial guidelines, published online just before former FDA Commissioner Marty Makary's resignation, allow manufacturers to launch certain nicotine products before regulators fully vet them.
According to agency insiders, key enforcement staff tasked with regulating the vaping industry were completely excluded from the decision-making process. Two FDA staffers, speaking on the condition of anonymity, revealed they only learned of the document the night before its release, sparking widespread internal confusion regarding who authorized the policy.
The six-page memo marks a drastic departure from established FDA protocol. Historically, the agency has strictly mandated that manufacturers provide scientific verification of a product's health benefits—specifically its potential to help adult smokers transition to less harmful alternatives—prior to market entry.
FDA officials have reportedly held hours-long emergency meetings to figure out how to implement the directive, which critics fear could flood the market with unregulated, unauthorized nicotine products.
